Adjusted OR and 95% CI for associations of patient- and condition-related factors* with adherence ≥ 80% in 1956 Kaiser Permanente patients with SLE and 2 recent prior fills of hydroxychloroquine, Northern California, 2006–14.
| Variables | Adjusted OR | 95% CI | p |
|---|---|---|---|
| Age, yrs | |||
| ≤ 39 | 1.00 | Ref. | |
| 40–49 | 0.92 | 0.72–1.18 | 0.51 |
| 50–64 | 1.39 | 1.09–1.76 | 0.01 |
| 65–89 | 1.44 | 1.07–1.93 | 0.02 |
| Race | |||
| African American | 0.74 | 0.56–0.97 | 0.03 |
| Asian/Pacific Islander | 0.76 | 0.59–0.99 | 0.04 |
| Hispanic | 0.59 | 0.44–0.77 | < 0.001 |
| White | 1.00 | Ref. | |
| Other/unknown | 0.67 | 0.49–0.92 | 0.01 |
| No. rheumatology visits | |||
| 0–1 | 1.00 | Ref. | |
| 2 | 1.30 | 1.01–1.67 | 0.04 |
| ≥ 3 | 1.47 | 1.18–1.83 | < 0.001 |
↵* Other factors in Table 1 were not associated with adherence to a significant degree in the adjusted model. The rheumatologist and the medical center also were not associated with adherence to a significant degree in the adjusted model. SLE: systemic lupus erythematosus.